Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years ; volume:21 ; number:1 ; day:6 ; month:5 ; year:2019 ; pages:1-10 ; date:12.2019
Breast cancer research ; 21, Heft 1 (6.5.2019), 1-10, 12.2019
- Urheber
-
Petridis, Christos
Arora, Iteeka
Shah, Vandna
Megalios, Anargyros
Moss, Charlotte
Mera, Anca
Clifford, Angela
Gillett, Cheryl
Pinder, Sarah E.
Tomlinson, Ian
Roylance, Rebecca
Simpson, Michael A.
Sawyer, Elinor J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-019-1143-y
- URN
-
urn:nbn:de:101:1-2019071921030646141308
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Petridis, Christos
- Arora, Iteeka
- Shah, Vandna
- Megalios, Anargyros
- Moss, Charlotte
- Mera, Anca
- Clifford, Angela
- Gillett, Cheryl
- Pinder, Sarah E.
- Tomlinson, Ian
- Roylance, Rebecca
- Simpson, Michael A.
- Sawyer, Elinor J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
LOH-Analysen von BRCA1-, BRCA2- und TP53-Markern in spontanen Mammakarzinomen
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
LOH-Analysen von BRCA1-, BRCA2- und TP53-Markern in spontanen Mammakarzinomen
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
LOH-Analysen von BRCA1-, BRCA2- und TP53-Markern in spontanen Mammakarzinomen
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland